Atlas Trials

Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma Cells

Clinical trial NCT04813653 · COMPLETED

Trial details

NCT number
NCT04813653
Sponsor
Tel-Aviv Sourasky Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
Start date
2021-04-18
Primary completion
2025-03-05
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.